ALBUQUERQUE, N.M. — Researchers plan to enroll some New Mexico injection-drug users infected with hepatitis C in a nationwide study seeking the most effective models for treating the liver-damaging disease.
The University of New Mexico will receive $2.3 million for the study to compare two models for treating the blood-borne virus, which is commonly transmitted by needle sharing among injection-drug users. UNM is one of eight U.S. sites that will participate in the $14 million five-year study, and treat an estimated 1,000 people nationally.
“UNM was selected because we have the clinical research infrastructure and support, and we’re committed to understanding and improving health disparities in New Mexico,” said Dr. Kimberly Page, a UNM professor of internal medicine, who will oversee UNM’s part of the study.
Labels: PCORI, People who inject drugs